T80.810 Extravasation of vesicant antineoplastic chemotherapy

Name of the Condition

• Extravasation of vesicant antineoplastic chemotherapy

Summary

This condition occurs when a vesicant antineoplastic chemotherapy drug leaks from a blood vessel into surrounding tissues. Vesicants are highly irritating drugs that can cause severe tissue damage when not administered properly.

Causes

Most commonly caused during intravenous (IV) administration of highly concentrated chemotherapy drugs where the drug leaks out of the vein.

Risk Factors

• High-risk factors include small veins, fragile veins often found in elderly patients, repeated cannulations, prior damage to veins from previous treatments, and inexperienced healthcare personnel administering chemotherapy.

Symptoms

• Patients may experience pain, swelling, redness, or a burning sensation at the site of the IV injection. If severe, there might be tissue necrosis leading to ulceration.

Diagnosis

Diagnosis is primarily based on clinical examination and patient history. Imaging tests such as ultrasound might be used to assess the extent of the leakage and damage.

Treatment Options

• Immediate cessation of the infusion of the drug.
• Application of ice or heat packs, depending on the protocol for the specific drug.
• Administration of antidotes or medications to neutralize the drug.
• Surgical intervention may be required in severe cases.

Prognosis and Follow-Up

Prognosis depends on the extent of tissue damage and timely intervention. Close monitoring is necessary to assess for complications and guide further treatment.

Complications

• Severe tissue necrosis, ulceration, infection, and potential loss of function in the affected area.

Lifestyle & Prevention

• Use of proper IV techniques, careful patient assessment for vein suitability, and training for healthcare personnel administering chemotherapy.

When to Seek Professional Help

• Seek immediate medical attention if pain, swelling, or redness at the injection site occurs during or after chemotherapy administration.

Tips for Medical Coders

• Document the specific type of vesicant antineoplastic chemotherapy involved, the site of extravasation, and any interventions performed. Ensure clear clinical correlation between the extravasation and the chemotherapy administration.